Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002951810 | SCV003684360 | likely benign | Inborn genetic diseases | 2022-01-26 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV003143556 | SCV003828810 | uncertain significance | not provided | 2021-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV003143556 | SCV004140845 | likely benign | not provided | 2023-03-01 | criteria provided, single submitter | clinical testing | CACNA1G: BS1 |
Labcorp Genetics |
RCV003143556 | SCV004277287 | benign | not provided | 2023-02-22 | criteria provided, single submitter | clinical testing |